The role of C5b-9 terminal complement complex in activation of the cell cycle and transcription

被引:69
作者
Fosbrink, M
Niculescu, F
Rus, H
机构
[1] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA
[2] Univ Maryland, Toxicol Program, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA
[4] Vet Adm Maryland Hlth Care Syst, Multiple Sclerosis Ctr Excellence, Baltimore, MD USA
关键词
C5b-9 terminal complement complex; cell cycle; proto-oncogenes; signal transduction; transcriptional regulation; RGC-32;
D O I
10.1385/IR:31:1:37
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Activation of the complement system plays an important role in innate and acquired immunity. Activation of complement and subsequent formation of C5b-9 channels on the surface of cellular membranes leads to cell lysis. When the number of channels assembled on the surface of nucleated cells is limited, C5b-9 does not cause lysis, but instead can induce cell-cycle progression by activating signal transduction pathways, transcription factors, and key components of the cell-cycle machinery. Cell-cycle induction by C56-9 is dependent on the activation of phosphatidylinositol 3-kinase and the ERK1 pathway in a Gi protein-dependent manner. Cell-cycle activation is regulated, in part, by activation of proto-oncogene c-jun and AP1 DNA binding activity. C5b-9 induces sequential activation of CDK4 and CDK2, leading to G1/S-phase transition and cellular proliferation. RGC-32 is a novel gene whose expression is induced by C5b-9. RGC-32 may play a key role in cell-cycle activation by increasing cyclin B1-CDC2 activity. C5b-9-mediated cell-cycle activation plays an important role in cellular proliferation and protection from apoptosis.
引用
收藏
页码:37 / 46
页数:10
相关论文
共 56 条
[1]   p38 Mitogen-activated protein kinase protects glomerular epithelial cells from complement-mediated cell injury [J].
Aoudjit, L ;
Stanciu, M ;
Li, HP ;
Lemay, S ;
Takano, T .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2003, 285 (04) :F765-F774
[2]   RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase [J].
Badea, T ;
Niculescu, F ;
Soane, L ;
Fosbrink, M ;
Sorana, H ;
Rus, V ;
Shin, ML ;
Rus, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (01) :502-508
[3]   Molecular cloning and characterization of RGC-32, a novel gene induced by complement activation in oligodendrocytes [J].
Badea, TC ;
Niculescu, FI ;
Soane, L ;
Shin, ML ;
Rus, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (41) :26977-26981
[4]   Sublytic terminal complement attack induces c-fos transcriptional activation in myotubes [J].
Badea, TD ;
Park, JH ;
Soane, L ;
Niculescu, T ;
Niculescu, F ;
Rus, H ;
Shin, ML .
JOURNAL OF NEUROIMMUNOLOGY, 2003, 142 (1-2) :58-66
[5]   TERMINAL COMPLEMENT PROTEINS C5B-9 RELEASE BASIC FIBROBLAST GROWTH-FACTOR AND PLATELET-DERIVED GROWTH-FACTOR FROM ENDOTHELIAL-CELLS [J].
BENZAQUEN, LR ;
NICHOLSONWELLER, A ;
HALPERIN, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (03) :985-992
[6]  
CARNEY DF, 1990, J IMMUNOL, V145, P623
[7]  
CARNEY DF, 1986, J IMMUNOL, V137, P263
[8]  
DALMASSO AP, 1981, J IMMUNOL, V127, P2214
[9]  
Darnell JE, 1996, RECENT PROG HORM RES, V51, P391
[10]   STATs and gene regulation [J].
Darnell, JE .
SCIENCE, 1997, 277 (5332) :1630-1635